Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas Biotech Investing
Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome Pharmaceutical Investing
AIT Therapeutics Announces Completion of the Agreement to License the Revolutionary Nitric Oxide Generator and Delivery System Pharmaceutical Investing
BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Esophageal Squamous Cell Carcinoma Pharmaceutical Investing
Vical Announces Restructuring to Focus Resources on HSV-2 and Antifungal Clinical Programs Pharmaceutical Investing
Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals Pharmaceutical Investing
Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology Biotech Investing
